Debellut F. et al.. Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries. PLoS One. 2018 Jun 22;13(6):e0199470.
Immunization of pregnant women against seasonal influenza remains limited in low- and lower-middle-income countries despite being recommended by the World Health Organization (WHO). The WHO/PATH Maternal Influenza Immunization Project was created to identify and address obstacles to delivering influenza vaccines to pregnant women in low resource setting. To gain a better understanding of potential demand from this target group, we developed a model simulating pregnant women populations eligible for vaccination during antenatal care (ANC) services in all low- and lower-middle-income countries. We assessed potential vaccine demand in the context of both seasonal and year-round vaccination strategies and identified the ways that immunization programs may be affected by availability gaps in supply linked to current vaccine production cycles and shelf life duration. Results of our analysis, which includes 54 eligible countries in 2015 for New Vaccine Support from Gavi, the Vaccine Alliance, suggest the demand for influenza vaccines could be 7.7 to 16.0 million doses in 2020, and 27.0 to 61.7 million doses by 2029. If current trends in production capacity and actual production of seasonal influenza vaccines were to continue, global vaccine supply would be sufficient to meet this additional demand—although a majority of countries would face implementation issues linked to timing of supply.
See Also:
Latest articles in those days:
- [preprint]Susceptibility of bovine respiratory and mammary epithelial cells to avian and mammalian derived clade 2.3.4.4b H5N1 highly pathogenic avian influenza viruses 19 hours ago
- Genetic Diversity of H10N3 Avian Influenza Virus Isolated from Anhui Province, China 20 hours ago
- Molecular origion of human infection with a novel avian influenza A H10N3 virus in China, 2021 20 hours ago
- Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice 20 hours ago
- GGCX promotes Eurasian avian-like H1N1 swine influenza virus adaption to interspecies receptor binding 20 hours ago
[Go Top] [Close Window]